Palleon Pharmaceuticals
Paul Crocker is a Professor of Glycoimmunology and Head of the Division of Cell Signaling and Immunology at the University of Dundee in Scotland. Paul is a world leader in the study of glycan-dependent regulation of immune and inflammatory responses. He pioneered the discovery of the Siglecs, a family of receptors found on immune cell surfaces that recognizes sialic acid-containing structures and regulates immune responses.
This person is not in the org chart
This person is not in any offices
Palleon Pharmaceuticals
Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.